Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
Sund, C., Belda, O., Borkakoti, N., Lindberg, J., Derbyshire, D., Vrang, L., Hamelink, E., Hgren, C., Woestenenk, E., Wikstrom, K., Eneroth, A., Lindstrom, E., Kalayanov, G.(2012) Bioorg Med Chem Lett 22: 6721-6727
- PubMed: 23010268 
- DOI: https://doi.org/10.1016/j.bmcl.2012.08.097
- Primary Citation of Related Structures:  
4EWO, 4EXG - PubMed Abstract: 
A set of low molecular weight compounds containing a hydroxyethylamine (HEA) core structure with different prime side alkyl substituted 4,5,6,7-tetrahydrobenzazoles and one 4,5,6,7-tetrahydropyridinoazole was synthesized. Striking differences were observed on potencies in the BACE-1 enzymatic and cellular assays depending on the nature of the heteroatoms in the bicyclic ring, from the low active compound 4 to inhibitor 6, displaying BACE-1 IC(50) values of 44 nM (enzyme assay) and 65 nM (cell-based assay).
Organizational Affiliation: 
Medivir AB, Lunastigen 7, SE-14144 Huddinge, Sweden.